Activity‐based costs of plasma transfusions in medical and surgical inpatients at a US hospital
- 25 February 2016
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 111 (1), 55-61
- https://doi.org/10.1111/vox.12386
Abstract
Background and objectives Fresh frozen plasma (FFP) usage has significantly increased over the last decade leading to elevated healthcare costs. Although FFP is used in several clinical settings, it is often inappropriately transfused and evidence for its clinical efficacy is poor. Here, we describe plasma usage and transfusion costs in a real-world US inpatient setting to determine the cost-effectiveness of FFP transfusion and for comparison to various patient blood management (PBM) options to treat coagulopathies. Materials and methods All activities related to plasma transfusion recorded at a single US hospital over one calendar year were collected in a stepwise manner using an activity-based costing (ABC) methodology. This model maps all technical, administrative and clinical processes inherent to the cost of plasma. Results Of 18 200 inpatients recorded, 849 were charged for blood products. In total, 136 medical and surgical inpatients were charged for 577 units of FFP, receiving a total of 534 units; 43 units were charged but not transfused. The total cost per unit of FFP transfused was $409.62 and $1,608.37 per patient transfused with FFP. Wasted products, in-hospital processes and overhead costs were found to account for 89.8% of the total cost of FFP transfusions. Conclusion This study is the first to use ABC methodology to determine the full cost of plasma transfusion in a US inpatient setting. These data reveal the true cost of plasma, providing a useful reference point to compare with the cost of other PBM options to manage coagulation disorders.Keywords
Funding Information
- CSL Behring
This publication has 44 references indexed in Scilit:
- An update of consensus guidelines for warfarin reversalThe Medical Journal of Australia, 2013
- Plasma in the PICU: why and when should we transfuse?Annals of Intensive Care, 2013
- Strategies to reduce the use of blood productsCurrent Opinion In Anesthesiology, 2012
- Transfusion‐related acute lung injury prevention measures and their impact at Canadian Blood ServicesTransfusion, 2011
- Transfusion‐associated circulatory overload after plasma transfusionTransfusion, 2011
- Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapyCritical Care, 2011
- Incidence and transfusion risk factors for transfusion‐associated circulatory overload among medical intensive care unit patientsTransfusion, 2010
- Activity‐based costs of blood transfusions in surgical patients at four hospitalsTransfusion, 2010
- The PROTON study: profiles of blood product transfusion recipients in the NetherlandsVox Sanguinis, 2010
- Cost and utilization of blood transfusion associated with spinal surgeries in the United StatesEuropean Spine Journal, 2006